These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 9854049)

  • 1. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
    J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade.
    Della Zuana O; Sadlo M; Germain M; Félétou M; Chamorro S; Tisserand F; de Montrion C; Boivin JF; Duhault J; Boutin JA; Levens N
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):84-94. PubMed ID: 11244462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
    Lecklin A; Lundell I; Paananen L; Wikberg JE; Männistö PT; Larhammar D
    Br J Pharmacol; 2002 Apr; 135(8):2029-37. PubMed ID: 11959807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists.
    Polidori C; Ciccocioppo R; Regoli D; Massi M
    Peptides; 2000 Jan; 21(1):29-35. PubMed ID: 10704716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central NPY-Y5 receptors activation plays a major role in fasting-induced pituitary-thyroid axis suppression in adult rat.
    Costa-e-Sousa RH; Souza LL; Calviño C; Cabanelas A; Almeida NA; Oliveira KJ; Pazos-Moura CC
    Regul Pept; 2011 Nov; 171(1-3):43-7. PubMed ID: 21771616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
    Gao J; Ghibaudi L; Hwa JJ
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E706-11. PubMed ID: 15187000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
    Duhault J; Boulanger M; Chamorro S; Boutin JA; Della Zuana O; Douillet E; Fauchère JL; Félétou M; Germain M; Husson B; Vega AM; Renard P; Tisserand F
    Can J Physiol Pharmacol; 2000 Feb; 78(2):173-85. PubMed ID: 10737680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.
    Della-Zuana O; Revereault L; Beck-Sickinger A; Monge A; Caignard DH; Fauchère JL; Henlin JM; Audinot V; Boutin JA; Chamorro S; Félétou M; Levens N
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):628-39. PubMed ID: 14758341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor.
    Kakui N; Tanaka J; Tabata Y; Asai K; Masuda N; Miyara T; Nakatani Y; Ohsawa F; Nishikawa N; Sugai M; Suzuki M; Aoki K; Kitaguchi H
    J Pharmacol Exp Ther; 2006 May; 317(2):562-70. PubMed ID: 16436501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
    Wieland HA; Engel W; Eberlein W; Rudolf K; Doods HN
    Br J Pharmacol; 1998 Oct; 125(3):549-55. PubMed ID: 9806339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
    Levens NR; Della-Zuana O
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1198-204. PubMed ID: 14649211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.